Detailed answers about YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED founded?
YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED was officially incorporated on 21 January 2026 and is registered under company number 16976980. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED?
YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED do?
YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED's registered address?
The registered office address of YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED is 28 LEEDS ROAD, ILKLEY, WEST YORKSHIRE, ENGLAND, LS29 8DS. This is the official address filed with Companies House for legal and statutory correspondence.
Is YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED financially stable?
Financial accounts for YORKSHIRE GENDER ENDOCRINOLOGY SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.